Postpartum Hemorrhage Medications

Maternity & Reproductive

Mark this drug class

Examples

oxytocinmethylergonovinecarboprostmisoprostoltranexamic acid

Prefix / Suffix: No consistent suffix

Physiology

After birth, the uterus must contract firmly to compress open placental blood vessels. If the uterus is boggy or clotting is impaired, bleeding can become life-threatening quickly.

Mechanism of Action

Uterotonics increase uterine tone to reduce bleeding. Tranexamic acid inhibits fibrinolysis, helping stabilize formed clots.

Indications

  • Prevention of postpartum hemorrhage
  • Treatment of uterine atony
  • Adjunct treatment for severe postpartum bleeding
  • Bleeding with suspected excessive clot breakdown

Side Effects / Adverse Effects

  • Hypertension with methylergonovine
  • Bronchospasm, fever, diarrhea with carboprost
  • Fever, chills, GI upset with misoprostol
  • Thromboembolism risk with tranexamic acid
  • Hypotension if oxytocin is pushed rapidly

Contraindications

  • Methylergonovine: hypertension or preeclampsia
  • Carboprost: asthma
  • Tranexamic acid: active intravascular clotting
  • Agent-specific allergy

Nursing Considerations

  • Assess fundus, lochia amount, clots, vital signs, and level of consciousness frequently
  • Massage boggy uterus and administer medications per hemorrhage protocol
  • Quantify blood loss instead of estimating visually
  • Maintain IV access and prepare fluids, blood products, and labs as ordered
  • Escalate early because postpartum hemorrhage can progress rapidly

Ask PharmPal Nurse

Your AI tutor for Postpartum Hemorrhage Medications

Ask me anything about this drug class.

Disclaimer: PharmPal Nurse is for education only and is not medical advice. Do not use it to diagnose, treat, prescribe, or make patient-care decisions; always verify with current drug references, your instructor, facility policy, and a licensed provider. In emergencies, call local emergency services.